Viewing Study NCT00267059


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2026-01-24 @ 9:14 PM
Study NCT ID: NCT00267059
Status: COMPLETED
Last Update Posted: 2012-08-07
First Post: 2005-12-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Lymphocytic Leukemia View
None Lenalidomide View
None Revlimid View
None CLL View